NZ511034A - Methods of downmodulating the immune response to therapeutic proteins - Google Patents
Methods of downmodulating the immune response to therapeutic proteinsInfo
- Publication number
- NZ511034A NZ511034A NZ511034A NZ51103499A NZ511034A NZ 511034 A NZ511034 A NZ 511034A NZ 511034 A NZ511034 A NZ 511034A NZ 51103499 A NZ51103499 A NZ 51103499A NZ 511034 A NZ511034 A NZ 511034A
- Authority
- NZ
- New Zealand
- Prior art keywords
- immune response
- downmodulating
- methods
- therapeutic proteins
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15817898A | 1998-09-21 | 1998-09-21 | |
| PCT/US1999/021991 WO2000016801A1 (en) | 1998-09-21 | 1999-09-21 | Methods of downmodulating the immune response to therapeutic proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ511034A true NZ511034A (en) | 2004-03-26 |
Family
ID=22566971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ511034A NZ511034A (en) | 1998-09-21 | 1999-09-21 | Methods of downmodulating the immune response to therapeutic proteins |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1115423A1 (hu) |
| JP (1) | JP2002526455A (hu) |
| KR (1) | KR20010085830A (hu) |
| CN (1) | CN1331602A (hu) |
| AU (1) | AU761206B2 (hu) |
| BR (1) | BR9913991A (hu) |
| CA (1) | CA2343916A1 (hu) |
| CZ (1) | CZ20011021A3 (hu) |
| EA (1) | EA005236B1 (hu) |
| HK (1) | HK1039059A1 (hu) |
| HU (1) | HUP0103960A3 (hu) |
| IL (1) | IL142069A0 (hu) |
| LT (1) | LT4920B (hu) |
| LV (1) | LV12768B (hu) |
| MX (1) | MXPA01002898A (hu) |
| NO (1) | NO20011412L (hu) |
| NZ (1) | NZ511034A (hu) |
| PL (1) | PL346796A1 (hu) |
| SI (1) | SI20626A (hu) |
| WO (1) | WO2000016801A1 (hu) |
| ZA (1) | ZA200103156B (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5397703A (en) | 1992-07-09 | 1995-03-14 | Cetus Oncology Corporation | Method for generation of antibodies to cell surface molecules |
| DE60118362T2 (de) * | 2000-05-19 | 2007-05-24 | The Center for Blood Research, Inc., Boston | VERFAHREN ZUR BEHANDLUNG VON HÄMOSTATISCHEN STÖRUNGEN DURCH LöSLICHES P-SELECTIN |
| US7040139B2 (en) * | 2003-06-10 | 2006-05-09 | Smiths Detection Inc. | Sensor arrangement |
| GB201508024D0 (en) | 2015-05-11 | 2015-06-24 | Haemostatix Ltd | Haemostatic compositions |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5171569A (en) | 1985-03-15 | 1992-12-15 | National Research Development Corporation | Factor IX preparations uncontaminated by plasma components or pox virus |
| US4868112A (en) | 1985-04-12 | 1989-09-19 | Genetics Institute, Inc. | Novel procoagulant proteins |
| US5422260A (en) | 1986-05-29 | 1995-06-06 | Genetics Institute, Inc. -Legal Affairs | Human factor VIII:c muteins |
| US4994371A (en) | 1987-08-28 | 1991-02-19 | Davie Earl W | DNA preparation of Christmas factor and use of DNA sequences |
| FR2657884B1 (fr) | 1990-02-05 | 1994-09-02 | Tm Innovation | Procede pour la preparation du facteur viii humain et d'analogues du facteur viii. |
| US5661008A (en) | 1991-03-15 | 1997-08-26 | Kabi Pharmacia Ab | Recombinant human factor VIII derivatives |
| US5770197A (en) | 1991-06-27 | 1998-06-23 | Bristol-Myers Squibb Company | Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules |
| AU661854B2 (en) | 1991-06-27 | 1995-08-10 | Bristol-Myers Squibb Company | CTL4A receptor, fusion proteins containing it and uses thereof |
| WO1993009804A1 (en) | 1991-11-18 | 1993-05-27 | The Scripps Research Institute | Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation |
| US5663060A (en) | 1992-04-07 | 1997-09-02 | Emory University | Hybrid human/animal factor VIII |
| US5744446A (en) | 1992-04-07 | 1998-04-28 | Emory University | Hybrid human/animal factor VIII |
| US5364771A (en) | 1992-04-07 | 1994-11-15 | Emory University | Hybrid human/porcine factor VIII |
| US5621039A (en) | 1993-06-08 | 1997-04-15 | Hallahan; Terrence W. | Factor IX- polymeric conjugates |
| WO1996005860A1 (en) * | 1994-08-19 | 1996-02-29 | Novo Nordisk A/S | A method of treating a patient with a biologically active compound |
| WO1996012406A1 (en) * | 1994-10-19 | 1996-05-02 | Genetic Therapy, Inc. | Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
| US5714583A (en) | 1995-06-07 | 1998-02-03 | Genetics Institute, Inc. | Factor IX purification methods |
| DK0892643T4 (da) * | 1996-03-20 | 2009-12-14 | Bristol Myers Squibb Co | Fremgangsmåder til inhibering af et immunrespons ved blokering af GP39/CD40- og CTLA4/CD28/B7-banerne og præparater til anvendelse derved |
| DE69837322T2 (de) * | 1997-01-10 | 2007-11-22 | Biogen Idec Ma Inc., Cambridge | Verfahren zur therapeutischen verabreichung von anti-cd40l-mitteln |
| CN1261285A (zh) * | 1997-06-20 | 2000-07-26 | 拜奥根有限公司 | 治疗性蛋白抑制剂综合症的cd154阻断治疗 |
| US8082673B2 (en) | 2009-11-06 | 2011-12-27 | Hexagon Metrology Ab | Systems and methods for control and calibration of a CMM |
-
1999
- 1999-09-21 CZ CZ20011021A patent/CZ20011021A3/cs unknown
- 1999-09-21 CA CA002343916A patent/CA2343916A1/en not_active Abandoned
- 1999-09-21 BR BR9913991-0A patent/BR9913991A/pt not_active IP Right Cessation
- 1999-09-21 IL IL14206999A patent/IL142069A0/xx unknown
- 1999-09-21 AU AU60578/99A patent/AU761206B2/en not_active Ceased
- 1999-09-21 CN CN99813510A patent/CN1331602A/zh active Pending
- 1999-09-21 JP JP2000573762A patent/JP2002526455A/ja not_active Withdrawn
- 1999-09-21 MX MXPA01002898A patent/MXPA01002898A/es unknown
- 1999-09-21 SI SI9920084A patent/SI20626A/sl not_active IP Right Cessation
- 1999-09-21 EP EP99969339A patent/EP1115423A1/en not_active Withdrawn
- 1999-09-21 NZ NZ511034A patent/NZ511034A/xx unknown
- 1999-09-21 KR KR1020017003611A patent/KR20010085830A/ko not_active Application Discontinuation
- 1999-09-21 EA EA200100385A patent/EA005236B1/ru not_active IP Right Cessation
- 1999-09-21 PL PL99346796A patent/PL346796A1/xx not_active Application Discontinuation
- 1999-09-21 WO PCT/US1999/021991 patent/WO2000016801A1/en not_active Application Discontinuation
- 1999-09-21 HU HU0103960A patent/HUP0103960A3/hu unknown
-
2001
- 2001-03-20 NO NO20011412A patent/NO20011412L/no not_active Application Discontinuation
- 2001-04-18 ZA ZA200103156A patent/ZA200103156B/xx unknown
- 2001-04-20 LV LVP-01-62A patent/LV12768B/lv unknown
- 2001-04-20 LT LT2001045A patent/LT4920B/lt not_active IP Right Cessation
-
2002
- 2002-01-10 HK HK02100157.7A patent/HK1039059A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200100385A1 (ru) | 2001-10-22 |
| LV12768A (en) | 2001-12-20 |
| NO20011412L (no) | 2001-05-16 |
| HK1039059A1 (zh) | 2002-04-12 |
| LV12768B (lv) | 2002-06-20 |
| CN1331602A (zh) | 2002-01-16 |
| ZA200103156B (en) | 2002-07-18 |
| CZ20011021A3 (cs) | 2001-10-17 |
| EP1115423A1 (en) | 2001-07-18 |
| HUP0103960A2 (hu) | 2002-02-28 |
| AU761206B2 (en) | 2003-05-29 |
| LT2001045A (en) | 2002-01-25 |
| NO20011412D0 (no) | 2001-03-20 |
| AU6057899A (en) | 2000-04-10 |
| IL142069A0 (en) | 2002-03-10 |
| EA005236B1 (ru) | 2004-12-30 |
| KR20010085830A (ko) | 2001-09-07 |
| LT4920B (lt) | 2002-06-25 |
| PL346796A1 (en) | 2002-02-25 |
| SI20626A (sl) | 2002-02-28 |
| WO2000016801A1 (en) | 2000-03-30 |
| BR9913991A (pt) | 2001-07-03 |
| HUP0103960A3 (en) | 2003-09-29 |
| JP2002526455A (ja) | 2002-08-20 |
| WO2000016801A9 (en) | 2000-10-26 |
| MXPA01002898A (es) | 2002-06-04 |
| CA2343916A1 (en) | 2000-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0643726T3 (da) | Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei | |
| EA200000445A1 (ru) | Способы лечения состояния гиперкоагуляции или приобретенной недостаточности белка c | |
| FI953442A0 (fi) | Gonadotropiinia sisältäviä pakastekuivattuja pallosia | |
| TR199903331T2 (xx) | Farnesil protein transferas engelleyicileri. | |
| ATE517922T1 (de) | Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation | |
| FI961621A (fi) | Proteiini:farnesyylitranseraasin substituoidut tetra- ja pentapeptidi-inhibiittorit | |
| CY1111863T1 (el) | Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων | |
| WO1998022136A3 (de) | Stabile lyophilisierte pharmazeutische zubereitungen von mono- oder polyklonalen antikörpern | |
| UA95438C2 (ru) | Биспецифические антитела, которые замещают функциональные белки | |
| IL127558A0 (en) | Hepatocyte growth factor receptor agonists and uses thereof | |
| IL160641A0 (en) | Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them | |
| CA2413190A1 (en) | Methods for treating rheumatic diseases using a soluble ctla4 molecule | |
| DK0836485T3 (da) | Kaskade-polymer-komplekser, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende disse | |
| DK0915974T3 (da) | Modificerede tie-2 receptor-ligander | |
| CY1109868T1 (el) | Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c | |
| WO2001068708A3 (en) | Human and humanized fap-alpha-specific antibodies | |
| AU6832398A (en) | Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof | |
| DE69434384D1 (de) | Metalkomplexbildner | |
| ATE234111T1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
| DK0845998T3 (da) | Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles | |
| EP1064005A4 (en) | USE OF THE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A TARGET IN THE DIAGNOSIS OF METASTASES | |
| MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
| NZ511034A (en) | Methods of downmodulating the immune response to therapeutic proteins | |
| KR950702207A (ko) | Tlp 복합체에 대한 항원성 부위와 이의 항체(antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them) | |
| PT723552E (pt) | Oligopeptidos derivados de fragmentos de proteina reactiva c |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: AMERICAN RED CROSS, US Free format text: OLD OWNER(S): AMERICAN RED CROSS; GENETICS INSTITUTE, INC. Owner name: GENETICS INSTITUTE, US Free format text: OLD OWNER(S): AMERICAN RED CROSS; GENETICS INSTITUTE, INC. |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |